维普期刊资源整合服务平台（V6.5）

30篇 您的检索式：作者名="LILLICRAP D"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Muhiyear therapeutic benefit of AAV serotypes 2,6 ,and 8 delivering factor Ⅷ to hemophilia A mice and dogs 显示文摘	Jiang H Lillicrap D Patarroyo-White S	2006	Blood2006，108，1：	1
2	Dangerous liaisons: the role of 'danger' signals in the immune response to gene therapy显示文摘	B D Brown D Lillicrap	2002	Blood2002，100，4：	1
3	Molecular diagnosis of inherited bleeding disorders and thrombophilia显示文摘		1999	Sem Hematol1999，36，：	1
4	Efficacy and safety of a new-class of hemostatic drug candidate,AV513,in hemophilia A dogs显示文摘	PRASAD S LILLICRAP D LABELLE A	2008	Blood2008，111，：	1
5	Defming the chronic impacts of atenolol on embryo - larval de?velopment and reproduction in the fathead minnow (Pimephales promelas)显示文摘	Winter MJ Lillicrap A D CaunterJ E	2008	Aquatic Toxicology2008，86，3：	1
6	Multi -year therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogs 显示文摘	Jiang H Lillicrap D Patarroyo-White S	2006	Blood2006，108，1：	1
7	Recombinant factor Ⅸ recovery and inhibitor safety: a Canadian post-licensure surveillance study 显示文摘	Poon MC Lillicrap D Hensman C	2002	Thromb Haemost2002，87，3：	1
8	The molecular basis of haemophilia B 显示文摘	Lillicrap D	1998	Haemophilia ttaemophilia1998，4，4：	1
9	Extending half-life in coagulation factors:where do we stand显示文摘	Lillicrap D		0，，04：	1
10	Can activated recombinant factor Ⅶ be used to postpone the exposure of infants to factor Ⅷ until after 2 years of age? 显示文摘	Rivard GE Lillicrap D Poon MC	2005	Haemophilia2005，11，4：	1
11	Muhiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogs显示文摘	Jiang H Lillicrap D Patarroyo-White S	2006	Blood2006，108，1：	1
12	Molecular modeling of the von Willebrand factor A2 Domain and the effects of associated type 2A von Willebrand disease mutations显示文摘	O'Brien LA Lillicrap D	2004	J Mol Model (Online)2004，10，4：	1
13	Dangerous liaisons: the role of 'danger' signals in the immune response to gene therapy 显示文摘	BrownD Lillicrap D	2002	Blood2002，100，4：	1
14	The molecular mechanisms of immuno modulation and tolerance induction to factor Ⅷ显示文摘	Waters B Lillicrap D	2009	J Thromb Haemost2009，7，14：	1
15	Hemophilia gene therapy:it's a matter of expression显示文摘	Lillicrap D	2004	Blood2004，103，1：	1
16	Multi-year therapeutic benefit of AAV serotypes 2,6 and 8 delivering factor VIII to hemophilia A mice and dog显示文摘	Jiang H Lillicrap D Patarroyo WS	2006	Blood2006，108，：	1
17	Multiplex analysis of two intragenic microsatellite repeat polymorphisms in the genetic diagnosis of haemophilia A显示文摘	Windsor S Taylor SAM Lillicrap D	1994	British Journal of Haematology1994，86，：	1
18	Dangerous liaisons: the role of 'danger' signals in the immune response to gene therapy 显示文摘	Brown BD Lillicrap D	2002	Blood2002，100，15：	1
19	Intensive exposure to factor Ⅷ is a risk factor for inhibitor development in mild hemophilia A显示文摘	Sharathkumar A Lillicrap D Blanchette V S	2003	J Thromb Haemost2003，1，6：	1
20	Premature stroke in family with lupus anticoagulant and antiphospholipid antibodies显示文摘	Brunet D Lillicrap DP	1990	Stroke1990，22，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示